Cooper-DeHoff RM - Search Results

1

Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes.

Davoodi-Semiromi A, Wasserfall CH, Hassanzadeh A, Cooper-DeHoff RM, Wabitsch M, Atkinson M. Davoodi-Semiromi A, et al. Immunogenetics. 2013 Jan;65(1):83-90. doi: 10.1007/s00251-012-0659-4. Epub 2012 Oct 19. Immunogenetics. 2013. PMID: 23081744 Free PMC article.

2

Correspondence regarding "Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats".

Davoodi-Semiromi A, Cooper-DeHoff R. Davoodi-Semiromi A, et al. Biochem Pharmacol. 2012 Mar 15;83(6):821. doi: 10.1016/j.bcp.2011.12.033. Epub 2011 Dec 30. Biochem Pharmacol. 2012. PMID: 22227275 No abstract available.

3

The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice.

Davoodi-Semiromi A, Wasserfall CH, Xia CQ, Cooper-DeHoff RM, Wabitsch M, Clare-Salzler M, Atkinson M. Davoodi-Semiromi A, et al. PLoS One. 2012;7(5):e36079. doi: 10.1371/journal.pone.0036079. Epub 2012 May 14. PLoS One. 2012. PMID: 22615750 Free PMC article.

4

Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.

Karnes JH, Cooper-DeHoff RM. Karnes JH, et al. Expert Rev Cardiovasc Ther. 2009 Jun;7(6):689-702. doi: 10.1586/erc.09.31. Expert Rev Cardiovasc Ther. 2009. PMID: 19505284 Free PMC article. Review.

5

Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study.

Cooper--DeHoff RM, Bird ST, Nichols GA, Delaney JA, Winterstein AG. Cooper--DeHoff RM, et al. J Am Heart Assoc. 2013 Jun 10;2(3):e000125. doi: 10.1161/JAHA.113.000125. J Am Heart Assoc. 2013. PMID: 23752710 Free PMC article.

6

Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?

Cooper-Dehoff RM, Hou W, Weng L, Baillie RA, Beitelshees AL, Gong Y, Shahin MH, Turner ST, Chapman A, Gums JG, Boyle SH, Zhu H, Wikoff WR, Boerwinkle E, Fiehn O, Frye RF, Kaddurah-Daouk R, Johnson JA. Cooper-Dehoff RM, et al. Circ Cardiovasc Genet. 2014 Apr;7(2):199-205. doi: 10.1161/CIRCGENETICS.113.000421. Epub 2014 Mar 13. Circ Cardiovasc Genet. 2014. PMID: 24627569 Free PMC article. Clinical Trial.

7

Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

Cooper-DeHoff RM, Pacanowski MA, Pepine CJ. Cooper-DeHoff RM, et al. J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S28-34. doi: 10.1016/j.jacc.2008.10.037. J Am Coll Cardiol. 2009. PMID: 19179214 Free PMC article. Review.

8

Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.

Cooper-DeHoff RM, Wen S, Beitelshees AL, Zineh I, Gums JG, Turner ST, Gong Y, Hall K, Parekh V, Chapman AB, Boerwinkle E, Johnson JA. Cooper-DeHoff RM, et al. Hypertension. 2010 Jan;55(1):61-8. doi: 10.1161/HYPERTENSIONAHA.109.139592. Epub 2009 Nov 16. Hypertension. 2010. PMID: 19917874 Free PMC article. Clinical Trial.

9

Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics.

Duarte JD, Cooper-DeHoff RM. Duarte JD, et al. Expert Rev Cardiovasc Ther. 2010 Jun;8(6):793-802. doi: 10.1586/erc.10.27. Expert Rev Cardiovasc Ther. 2010. PMID: 20528637 Free PMC article. Review.

10

Atenolol exposure and risk for development of adverse metabolic effects: a pilot study.

Navare HA, Frye RF, Cooper-Dehoff RM, Shuster JJ, Hall K, Schmidt SO, Turner ST, Johnson JA. Navare HA, et al. Pharmacotherapy. 2010 Sep;30(9):872-8. doi: 10.1592/phco.30.9.872. Pharmacotherapy. 2010. PMID: 20795842 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters